Title : Broad antiviral and anti-inflammatory efficacy of nafamostat against SARS-CoV-2 and seasonal coronaviruses in primary human bronchiolar epithelia.

Pub. Date : 2021 Jun 30

PMID : 34541574

1 Functional Relationships(s)
Compound Name
Protein Name
1 Here, we evaluate nafamostat mesylate, a potent broad-spectrum serine protease inhibitor that blocks host protease activation of the viral spike protein. nafamostat surface glycoprotein Severe acute respiratory syndrome coronavirus 2